Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for Resistant Major Depression
NCT05324735Phase 2Completed
- Sponsor
- Hawler Medical University
- Start
- Dec 2021
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pentoxifylline in bipolar disorder (BD), sponsored by Hawler Medical University. Started Dec 2021; status: completed.
02
Drugs
pentoxifylline
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT05324735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05324735.